Atlas Trials

Iontophoretic Delivery of EGP-437 in Patients Who Have Undergone Cataract Surgery

Clinical trial NCT03180255 · COMPLETED

Trial details

NCT number
NCT03180255
Sponsor
Eyegate Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
CataractAnterior Chamber InflammationPain, Postoperative
Start date
2017-07-26
Primary completion
2017-11-07
Enrollment
101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.